title: Treatment of thalassaemia major with phenylbutyrate and hydroxyurea.
authors.forename: N F
authors.initials: NF
authors.lastname: Olivieri
authors.forename: D C
authors.initials: DC
authors.lastname: Rees
authors.forename: G D
authors.initials: GD
authors.lastname: Ginder
authors.forename: S L
authors.initials: SL
authors.lastname: Thein
authors.forename: G M
authors.initials: GM
authors.lastname: Brittenham
authors.forename: J S
authors.initials: JS
authors.lastname: Waye
authors.forename: D J
authors.initials: DJ
authors.lastname: Weatherall
mesh_terms: D000328:Adult; D000986:Antisickling Agents / Q000627:therapeutic use*; D001803:Blood Transfusion; D002648:Child; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male; D010654:Phenylbutyrates / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000986:Antisickling Agents; D010654:Phenylbutyrates; D006918:Hydroxyurea